⚠ FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All information presented is for educational and research reference purposes only.
⚠ FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All information presented is for educational and research reference purposes only.
Metabolic Research Compound
GLP-2 (TRZ)
- Synthetic Peptide
- Dual GIP/GLP-1 Receptor Agonist
- 39 Amino Acid Peptide
GLP-2 (TRZ) is a synthetic peptide commonly utilized in laboratory research involving metabolic regulation, endocrine signaling pathways, and energy balance mechanisms. Supplied as a high purity lyophilized peptide for research applications.
$84.00
Fast Shipping
Free shipment protection
Overnight shipping available
Fast Shipping
Protected
Overnight Available
Free shipping
on orders over $150
Damage
protection
Secure checkout
256-bit SSL
USA Shipping
Free over $150
COA
Verified
Secure checkout
256-bit SSL
Certificate of Analysis
Third Party Tested
- LATEST
- ISO 17025
- 7x TESTING
99.91%
PURITY
- Passed full QC Panel
Variant
GLP-2 (TRZ) 10mg
Lot #
BL240513-01
Labeled
10mg
Actual
12.32mg
Tested
June 29th, 2026
Full QC Panel
7× tested
Purity (HPLC)
- 99.91%
Net Peptide Content
- 12.30mg
Identity (HPLC)
- Tirzepatide
HPLC Conformity
Heavy Metals (ICP-MS)
- Not detected
Sterility (PCR)
- No growth
Endotoxin (USP )
- < 0.05 EU/mL
ISO/IEC 17025 Accredited
- LATEST
- ISO 17025
- 7x TESTING
99.76%
PURITY
- Passed full QC Panel
Variant
Tirzepatide 20mg
Lot #
BL240513-01
Labeled
20mg
Actual
22.66mg
Tested
June 29th, 2026
Full QC Panel
7× tested
Purity (HPLC)
- 99.76%
Net Peptide Content
- 22.66mg
Identity (HPLC)
- Tirzepatide
HPLC Conformity
Heavy Metals (ICP-MS)
- Not Detected
Sterility (PCR)
- No Growth
Endotoxin (USP )
- < 0.05 EU/mL
ISO/IEC 17025 Accredited
- LATEST
- ISO 17025
- 7x TESTING
99.676%
PURITY
- Passed full QC Panel
Variant
Tirzepatide 30mg
Lot #
BL240513-01
Labeled
30mg
Actual
35.76mg
Tested
June 29th, 2026
Full QC Panel
7× tested
Purity (HPLC)
- 99.676%
Net Peptide Content
- 35.76mg
Identity (HPLC)
- Tirzepatide
HPLC Conformity
Heavy Metals (ICP-MS)
- Not Detected
Sterility (PCR)
- No Growth
Endotoxin (USP )
- < 0.05 EU/mL
ISO/IEC 17025 Accredited
- LATEST
- ISO 17025
- 7x TESTING
99.84%
PURITY
- Passed full QC Panel
Variant
Tirzepatide 40mg
Lot #
BL240513-01
Labeled
40mg
Actual
41.95mg
Tested
June 29th, 2026
Full QC Panel
7× tested
Purity (HPLC)
- 99.84%
Net Peptide Content
- 41.95mg
Identity (HPLC)
- Tirzepatide
HPLC Conformity
Heavy Metals (ICP-MS)
- Not Detected
Sterility (PCR)
- No Growth
Endotoxin (USP )
- < 0.05 EU/mL
ISO/IEC 17025 Accredited
- LATEST
- ISO 17025
- 7x TESTING
99.69%
PURITY
- Passed full QC Panel
Variant
Tirzepatide 60mg
Lot #
BL240513-01
Labeled
60mg
Actual
61.53mg
Tested
June 29th, 2026
Full QC Panel
7× tested
Purity (HPLC)
- 99.69%
Net Peptide Content
- 61.53mg
Identity (HPLC)
- Tirzepatide
HPLC Conformity
Heavy Metals (ICP-MS)
- Not Detected
Sterility (PCR)
- No Growth
Endotoxin (USP )
- < 0.05 EU/mL
ISO/IEC 17025 Accredited
- LATEST
- ISO 17025
- 7x TESTING
99.91%
PURITY
- Passed full QC Panel
Variant
GLP-2 (TRZ) 10mg
Lot #
BL240513-01
Labeled
10mg
Actual
12.32mg
Tested
June 29th, 2026
Full QC Panel
7× tested
Purity (HPLC)
- 99.91%
Net Peptide Content
- 12.30mg
Identity (HPLC)
- Tirzepatide
HPLC Conformity
Heavy Metals (ICP-MS)
- Not detected
Sterility (PCR)
- No growth
Endotoxin (USP )
- < 0.05 EU/mL
ISO/IEC 17025 Accredited
- LATEST
- ISO 17025
- 7x TESTING
99.76%
PURITY
- Passed full QC Panel
Variant
Tirzepatide 20mg
Lot #
BL240513-01
Labeled
20mg
Actual
22.66mg
Tested
June 29th, 2026
Full QC Panel
7× tested
Purity (HPLC)
- 99.76%
Net Peptide Content
- 22.66mg
Identity (HPLC)
- Tirzepatide
HPLC Conformity
Heavy Metals (ICP-MS)
- Not Detected
Sterility (PCR)
- No Growth
Endotoxin (USP )
- < 0.05 EU/mL
ISO/IEC 17025 Accredited
- LATEST
- ISO 17025
- 7x TESTING
99.676%
PURITY
- Passed full QC Panel
Variant
Tirzepatide 30mg
Lot #
BL240513-01
Labeled
30mg
Actual
35.76mg
Tested
June 29th, 2026
Full QC Panel
7× tested
Purity (HPLC)
- 99.676%
Net Peptide Content
- 35.76mg
Identity (HPLC)
- Tirzepatide
HPLC Conformity
Heavy Metals (ICP-MS)
- Not Detected
Sterility (PCR)
- No Growth
Endotoxin (USP )
- < 0.05 EU/mL
ISO/IEC 17025 Accredited
- LATEST
- ISO 17025
- 7x TESTING
99.84%
PURITY
- Passed full QC Panel
Variant
Tirzepatide 40mg
Lot #
BL240513-01
Labeled
40mg
Actual
41.95mg
Tested
June 29th, 2026
Full QC Panel
7× tested
Purity (HPLC)
- 99.84%
Net Peptide Content
- 41.95mg
Identity (HPLC)
- Tirzepatide
HPLC Conformity
Heavy Metals (ICP-MS)
- Not Detected
Sterility (PCR)
- No Growth
Endotoxin (USP )
- < 0.05 EU/mL
ISO/IEC 17025 Accredited
- LATEST
- ISO 17025
- 7x TESTING
99.69%
PURITY
- Passed full QC Panel
Variant
Tirzepatide 60mg
Lot #
BL240513-01
Labeled
60mg
Actual
61.53mg
Tested
June 29th, 2026
Full QC Panel
7× tested
Purity (HPLC)
- 99.69%
Net Peptide Content
- 61.53mg
Identity (HPLC)
- Tirzepatide
HPLC Conformity
Heavy Metals (ICP-MS)
- Not Detected
Sterility (PCR)
- No Growth
Endotoxin (USP )
- < 0.05 EU/mL
ISO/IEC 17025 Accredited
compound information
Technical specifications
- Molecular Profile
GLP-2 (TRZ)
White to off-white lyophilized powder (cake)
type
Synthetic Peptide
CAS Number
2023788-19-2
Molecular Weight
4,813.45 g/mol
Salt Form
Acetate
Molecular Formula
C₂₂₅H₃₄₈N₄₈O₆₈
Appearance
White to off-white lyophilized powder (cake)
- Storage Requirements
Stability Information
Handle with care to maintain potency
Lyophilized (powder)
-20°C long-term
Short-term storage
2-8°C • use within 30 days
Reconstituted
Store away from light
Sources & References
Peer-reviewed research
- Obesity / weight reduction
GLP-2 once weekly for the treatment of obesity
Year: 2022
PMID : 35658024
The New England Journal of Medicine
- Type 2 diabetes / GLP-1 comparison
GLP-2 versus GLP-1 once weekly in patients with type 2 diabetes
Year: 2021
PMID : 34170647
The New England Journal of Medicine
- Obesity / diabetes prevention
GLP-2 for obesity treatment and diabetes prevention
Year: 2022
PMID : 35658024
The New England Journal of Medicine
⚠
Important Research Notice
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.